
Work Here?
Ultralight Labs builds a lightweight, cloud-based platform for medical device teams to manage regulatory compliance. It integrates requirements management, risk assessment, and end-to-end traceability into one easy-to-use system, helping engineering, quality, and regulatory staff collaborate and stay compliant without slowing development. The product is offered on a subscription basis, providing ongoing updates and support. Unlike heavier, complex compliance tools, Ultralight Labs focuses on speed and simplicity to reduce time, cost, and friction in getting medical devices to market. The company's goal is to accelerate medical device innovation by making critical compliance workflows faster and easier to manage.
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
1-10
Company Stage
Seed
Total Funding
$2.7M
Headquarters
New York City, New York
Founded
2022
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$2.7M
Below
Industry Average
Funded Over
1 Rounds
Industry standards
Ultralight, an AI-native operating system for modern medicine, has raised $9.3 million in seed funding led by The General Partnership. Wisdom Ventures, Anthemis Group, Emerson Collective, GSBackers and various angel investors participated in the round. The platform automates administrative tasks and provides clinical insights for functional, integrative and longevity practices. Ultralight unifies electronic health records, practice management and patient engagement in a single vertical SaaS stack with integrated AI capabilities. Wilson Sonsini Goodrich & Rosati advised Ultralight on the transaction, with Lang Liu and Oliver Zhou leading the team.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
1-10
Company Stage
Seed
Total Funding
$2.7M
Headquarters
New York City, New York
Founded
2022
Find jobs on Simplify and start your career today